MYOCARDIAL VIABILITY ASSESSMENT IN ISCHEMIC CARDIOMYOPATHY - BENEFITS OF CORONARY REVASCULARIZATION

被引:149
|
作者
DREYFUS, GD
DUBOC, D
BLASCO, A
VIGONI, F
DUBOIS, C
BRODATY, D
DELENTDECKER, P
BACHET, J
GOUDOT, B
GUILMET, D
机构
[1] Department of Cardio-Vascular Surgery and Transplantation, Hôpital Foch, Paris V University, Suresnes
来源
ANNALS OF THORACIC SURGERY | 1994年 / 57卷 / 06期
关键词
D O I
10.1016/0003-4975(94)90091-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Patients with ischemic heart disease, congestive heart failure, and low ejection fraction are usually referred for orthotopic heart transplantation. Based on results of myocardial viability assessment, we have prospectively used either coronary artery bypass grafting or orthotopic heart transplantation. From January 1990 to June 1992, among 50 patients initially referred for heart transplantation, 46 showing myocardial viability underwent bypass grafting. Forty-five of these 46 patients were men, and the mean age was 58 +/- 12 years (range, 40 to 70 years). Congestive heart failure was present in all patients, and dyspnea was the main symptom in 80% (37/46). Patients were selected according to three criteria. (1) Myocardial viability was primarily assessed by thallium scintigraphy for up to 24 hours (28/46 patients). When results were negative, patients underwent positron emission tomography (20/46 patients). (2) Regional left ventricular function was assessed using gated blood pool single-photon emission computed tomography combined with (3) full hemodynamic evaluation. Results were as follows: end-diastolic volume, 129 +/- 35 mL/m(2); ejection fraction, 0.23 +/- 0.06; cardiac index, 2.4 +/- 0.62 L . min(-1) . m(-2); mean pulmonary artery pressure, 26 +/- 0.90 mm Hg; and mean pulmonary capillary wedge pressure, 16 +/- 1.10 mm Hg. Operative mortality was 2.17% (1/46). During follow-up (mean duration, 18 months), there were three late cardiac-related deaths (arrhythmias) and two noncardiac-related deaths. The 40 long-term survivors are in New York Heart Association class II. Angiography (15 patients) or gated blood pool single photon emission tomography (32) showed improvement in mean ejection fraction to 0.39 +/- 0.13 (range, 0.22 to 0.46). We therefore recommend coronary artery bypass grafting as an alternative to orthotopic heart transplantation whenever myocardial viability is detected by thallium scintigraphy or positron emission tomography, cardiac index is 1.5 L . min(-1) . m(-2) or higher, and mean pulmonary pressure is 40 mm Hg or lower.
引用
收藏
页码:1402 / 1408
页数:7
相关论文
共 50 条
  • [1] Myocardial Viability Assessment Before Surgical Revascularization in Ischemic Cardiomyopathy JACC Review Topic of the Week
    Panza, Julio A.
    Chrzanowski, Lukasz
    Bonow, Robert O.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 78 (10) : 1068 - 1077
  • [2] Effect of coronary revascularization in patients with ischemic cardiomyopathy who satisfy viability criteria on gated-SPECT assessment of myocardial perfusion
    Romero-Farina, Guillermo
    Candell-Riera, Jaume
    Aguade-Bruix, Santiago
    de Leon, Gustavo
    Castell-Conesa, Joan
    REVISTA ESPANOLA DE CARDIOLOGIA, 2008, 61 (05): : 540 - 544
  • [3] Assessment of myocardial viability: an effective gatekeeper for coronary revascularization?
    Yao, Siu-Sun
    Chaudhry, Farooq A.
    FUTURE CARDIOLOGY, 2008, 4 (05) : 443 - 447
  • [4] Myocardial feature tracking for viability assessment in ischemic cardiomyopathy
    Andreas Schuster
    Matthias Paul
    Nuno Bettencourt
    Tarique Hussain
    Dirk Lossnitzer
    Masaki Ishida
    Amedeo Chiribiri
    Boris Bigalke
    Geraint Morton
    Divaka Perera
    Gerald Greil
    Eike Nagel
    Journal of Cardiovascular Magnetic Resonance, 13 (Suppl 1)
  • [5] Coronary revascularization in ischemic cardiomyopathy
    Westaby, S
    SURGICAL CLINICS OF NORTH AMERICA, 2004, 84 (01) : 179 - +
  • [6] Opposite patterns of left ventricular remodeling after coronary revascularization in patients with ischemic cardiomyopathy - Role of myocardial viability
    Rizzello, V
    Poldermans, D
    Boersma, E
    Biagini, E
    Schinkel, AFL
    Krenning, B
    Elhendy, A
    Vourvouri, EC
    Sozzi, FB
    Maat, A
    Crea, F
    Roelandt, JRTC
    Bax, JJ
    CIRCULATION, 2004, 110 (16) : 2383 - 2388
  • [7] Myocardial viability assessment and utility in contemporary management of ischemic cardiomyopathy
    Katikireddy, Chandra K.
    Samim, Arang
    CLINICAL CARDIOLOGY, 2022, 45 (02) : 152 - 161
  • [8] Coronary artery surgery for ischemic heart failure: Risks, benefits, and the importance of assessment of myocardial viability
    Pitt, M
    Lewis, ME
    Bonser, RS
    PROGRESS IN CARDIOVASCULAR DISEASES, 2001, 43 (05) : 373 - 386
  • [9] Assessing myocardial viability in ischemic cardiomyopathy
    Chaudhry, FA
    Iskandrian, AE
    ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES, 2005, 22 (01): : 57 - 57
  • [10] MYOCARDIAL VIABILITY AND OUTCOMES IN ISCHEMIC CARDIOMYOPATHY
    Shirani, J.
    CARDIOLOGY, 2013, 125 : 31 - 31